Kumar, Nitin
Thompson, Christopher C. http://orcid.org/0000-0002-6105-5270
Funding for this research was provided by:
National Institutes of Health (P30 DK034854, T32 DK007533)
Article History
Received: 20 December 2016
Accepted: 16 May 2017
First Online: 10 August 2017
Compliance with ethical standards
:
: Dr. Nitin Kumar is a consultant for Obalon Therapeutics. Dr. Christopher C. Thompson is a consultant for Boston Scientific, Covidien, USGI Medical, Olympus, Apollo Endosurgery, and Fractyl. Dr. Thompson is an advisory board member for USGI Medical and Fratcyl, and an expert reviewer for GI Dynamics. Dr. Thompson has ownership interest in GI Windows. Dr. Thompson received research Grants from USGI Medical, Aspire Bariatrics, and Spatz. Drs. Nitin Kumar and Christopher C. Thompson have no conflicts of interest or financial ties to disclose.